Lactobacillus Plantarum for Cholesterol Management

Research suggests that Lactobacillus plantarum, when combined with other probiotic strains in a yogurt formulation, may contribute to improvements in cholesterol, triglycerides, LDL, and HDL levels in the context of metabolic liver disease. The available evidence here consists of a single animal study from 2024, in which rats fed a high-fat diet showed measurable lipid improvements when given a multi-strain probiotic yogurt that included L. plantarum alongside three other bacterial strains, making it difficult to isolate the specific contribution of L. plantarum alone. Because this research was conducted in rats rather than humans, and used a combination product rather than L. plantarum in isolation, the findings, while promising, cannot be directly applied to human cholesterol management at this time. Broader research in this area warrants attention, but the current evidence base reviewed here is limited in scope and generalizability.